News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,414 Results
Type
Article (43454)
Company Profile (349)
Press Release (690601)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (207948)
Career Advice (2058)
Deals (35986)
Drug Delivery (111)
Drug Development (82117)
Employer Resources (173)
FDA (16582)
Job Trends (15187)
News (351409)
Policy (33275)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2659)
Academic (1)
Accelerated approval (33)
Adcomms (24)
Allergies (143)
Alliances (50767)
ALS (172)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (315)
Approvals (16850)
Artificial intelligence (520)
Autoimmune disease (161)
Automation (41)
Bankruptcy (369)
Best Places to Work (11729)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (233)
Bladder cancer (157)
Brain cancer (58)
Breast cancer (646)
Cancer (4863)
Cardiovascular disease (405)
Career advice (1741)
Career pathing (37)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (747)
Cervical cancer (37)
Clinical research (70057)
Collaboration (1736)
Company closure (4)
Compensation (1174)
Complete response letters (56)
COVID-19 (2768)
CRISPR (94)
C-suite (871)
Cystic fibrosis (143)
Data (6276)
Decentralized trials (2)
Denatured (26)
Depression (135)
Diabetes (503)
Diagnostics (6885)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (259)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90870)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (119010)
Executive appointments (992)
FDA (19720)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1493)
Gene editing (203)
Generative AI (43)
Gene therapy (601)
GLP-1 (980)
Government (4715)
Grass and pollen (6)
Guidances (384)
Healthcare (19059)
HIV (61)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (255)
Immuno-oncology (57)
Indications (114)
Infectious disease (3045)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (253)
Interviews (319)
IPO (16773)
IRA (50)
Job creations (3805)
Job search strategy (1458)
JPM (58)
Kidney cancer (16)
Labor market (86)
Layoffs (561)
Leadership (33)
Legal (8088)
Liver cancer (91)
Longevity (14)
Lung cancer (654)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (800)
MASH (166)
Medical device (13856)
Medtech (13910)
Mergers & acquisitions (20289)
Metabolic disorders (1275)
Multiple sclerosis (163)
NASH (17)
Neurodegenerative disease (319)
Neuropsychiatric disorders (88)
Neuroscience (2935)
Neurotech (1)
NextGen: Class of 2026 (6622)
Non-profit (4585)
Now hiring (67)
Obesity (598)
Opinion (268)
Ovarian cancer (167)
Pain (199)
Pancreatic cancer (230)
Parkinson's disease (281)
Partnered (34)
Patents (501)
Patient recruitment (493)
Peanut (57)
People (59968)
Pharmaceutical (74)
Pharmacy benefit managers (29)
Phase 1 (21875)
Phase 2 (30804)
Phase 3 (22954)
Pipeline (5382)
Policy (283)
Postmarket research (2594)
Preclinical (9371)
Press Release (67)
Prostate cancer (242)
Psychedelics (48)
Radiopharmaceuticals (296)
Rare diseases (844)
Real estate (6222)
Recruiting (70)
Regulatory (24893)
Reports (53)
Research institute (2461)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (149)
Series A (242)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (159)
Sponsored (45)
Startups (3699)
State (2)
Stomach cancer (17)
Supply chain (106)
Tariffs (84)
The Weekly (54)
Vaccines (1015)
Venture capital (89)
Weight loss (383)
Women's health (92)
Worklife (19)
Date
Today (183)
Last 7 days (557)
Last 30 days (2239)
Last 365 days (30159)
2026 (3688)
2025 (30431)
2024 (35611)
2023 (40450)
2022 (51601)
2021 (56219)
2020 (54663)
2019 (47114)
2018 (35467)
2017 (32677)
2016 (32247)
2015 (38263)
2014 (32046)
2013 (27151)
2012 (29310)
2011 (29980)
2010 (28033)
Location
Africa (754)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (40179)
Australia (6578)
California (11376)
Canada (3310)
China (1118)
Colorado (481)
Connecticut (480)
Delaware (340)
Europe (87849)
Florida (1699)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (867)
India (67)
Indiana (526)
Iowa (22)
Japan (434)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1393)
Massachusetts (8355)
Michigan (327)
Minnesota (634)
Mississippi (5)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3025)
New Mexico (29)
New York (3000)
North Carolina (1485)
North Dakota (8)
Northern California (5548)
Ohio (343)
Oklahoma (21)
Oregon (41)
Pennsylvania (2290)
Puerto Rico (24)
Rhode Island (49)
South America (1140)
South Carolina (66)
South Dakota (1)
Southern California (4435)
Tennessee (175)
Texas (1767)
United States (40574)
Utah (340)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (927)
West Virginia (4)
Wisconsin (113)
Wyoming (2)
734,414 Results for "cambridge isotope laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
October 28, 2025
·
3 min read
Press Releases
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
May 20, 2025
·
1 min read
Genetown
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Cambridge Isotope Laboratories, Inc. has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations Xenia, Ohio location.
April 25, 2024
·
2 min read
Business
Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production
Cambridge Isotope Laboratories, Inc., the world leader in stable isotope chemistry and the separation of carbon-13, has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company.
March 15, 2024
·
2 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project
September 6, 2024
·
2 min read
Genetown
Cambridge Isotope Laboratories, Inc. (CIL) Partners With ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts
Cambridge Isotope Laboratories, Inc. has partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude Lipid Yeast Extracts.
September 26, 2022
·
3 min read
Press Releases
Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand
September 18, 2025
·
6 min read
Press Releases
Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India
February 18, 2026
·
6 min read
Business
Cambridge Isotope Laboratories Appoints John Bakke as Vice President of Finance
Cambridge Isotope Laboratories, Inc., the world’s leading manufacturer of stable isotopes and stable isotope-labeled compounds, is pleased to announce the addition of John Bakke as Vice President of Finance.
August 15, 2022
·
2 min read
1 of 73,442
Next
